Bryan M. Reasons, CFO at Amneal Pharmaceuticals, Inc. (AMRX), sold 23,396 shares at $23.65 ($553K) on 2018-08-21, disclosed to the SEC on 2018-08-23.
Open-market sale of $553k AMRX by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.65 | 11,698 | $277K | 50.0% |
| 2 | $23.65 | 11,698 | $277K | 50.0% |
| Total | $23.65 avg | 23,396 | $553K | 100% |
| Filing → |
| MNK | BUY | 2019-06-07 | $48K | — | Filing → |